Domestic broking firm ICICIdirect has set Nifty target for December 2024 at 25,000 by valuing the index at 20x PE on FY26E EPS of Rs 1,250 per share with corresponding Sensex target set as 83,250
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale